1. Home
  2. COHU vs GHRS Comparison

COHU vs GHRS Comparison

Compare COHU & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohu Inc.

COHU

Cohu Inc.

BUY

Current Price

$47.96

Market Cap

1.9B

Sector

Industrials

ML Signal

BUY

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$18.02

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHU
GHRS
Founded
1947
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
COHU
GHRS
Price
$47.96
$18.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
10
Target Price
★ $70.88
$42.89
AVG Volume (30 Days)
★ 973.1K
328.4K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $452,956,000.00
N/A
Revenue This Year
$35.26
N/A
Revenue Next Year
$25.65
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 12.74
N/A
52 Week Low
$21.10
$12.04
52 Week High
$75.72
$31.44

Technical Indicators

Market Signals
Indicator
COHU
GHRS
Relative Strength Index (RSI) 35.37 26.81
Support Level $42.68 $13.19
Resistance Level $58.35 $22.88
Average True Range (ATR) 3.63 1.05
MACD -2.41 0.01
Stochastic Oscillator 8.66 10.78

Price Performance

Historical Comparison
COHU
GHRS

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads, and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection). Geographically, the company generates maximum revenue from the Philippines, followed by Taiwan, China, Malaysia, the United States, Singapore, and the Rest of the world.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: